Print this page    •   Back to Web version of article

Viracept (Nelfinavir) Label Change Reflects Drug-Drug Interaction Information With Warfarin

February 24, 2011

On February 24, 2011, FDA updated the Viracept (nelfinavir) label to include drug-drug interaction information between nelfinavir and wafarin.

Table 11 (Established and Other Potentially Significant Drug Interactions) of the Precautions section of the label was changed to add the following:

Coadministration of wafarin and Viracept may affect concentrations of wafarin. It is recommended that the INR (international normalized ratio) be monitored carefully during treatment with Viracept, especially when commencing therapy.

The complete, revised label will be posted soon at Drugs@FDA




This article was provided by U.S. Food and Drug Administration. You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/art60630.html

General Disclaimer: TheBody.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBody.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.